DV
Dividend Vision

ARTL — Artelo Biosciences Inc

Artelo Biosciences Inc (ARTL)

Total return is -80.2% over the past 8.7 years, 325.1 points behind SPY at 244.9%. Its deepest 1-year drawdown was 97.7%.

ARTL is an equity stock that operates in the biosciences sector. The fund does not currently distribute dividends, as indicated by its N/A distribution rate and frequency. This security appeals primarily to growth-oriented investors seeking exposure to the biosciences industry rather than those focused on generating current income.

ARTL key facts

Asset type
Stock
Asset class
Equity
Inception date
11/14/2017
Last close
$0.79
Market cap
$4,008,371
Average volume
448000.0
Payment date
06/21/2019
Beta
-0.111
Payout ratio
0.0
Forward P/E
0.0
EPS
$-29.01